This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Unwanted effects

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Evidence from a randomised controlled trial comparing the effectiveness of hormonal emergency contraceptives showed that various unwanted effects were less common with levonorgestrel than with the Yuzpe regimen (1):

  • nausea (23% vs. 50% of women)
  • vomiting (6% vs. 19% of women)
  • fatigue (17% vs. 29% of women)
  • dizziness (11% vs. 17% of women)

Other unwanted effects that occurred in similar frequencies with both regimens included headache (17% in levonorgestrel group), breast tenderness (11% in levonorgestrel group), and lower abdominal pain (18% in levonorgestrel group).

Less common unwanted effects that occurred with both regimens included irregular bleeding/spotting and diarrhoea.

Reference:

  • (1) Task Force on Postovulatory Methods of Fertility Regulation (1998). Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet, 352, 428-33.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.